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Abstract
The disproportionate burden of prevalent, persistent pathogens among disadvantaged groups
may contribute to socioeconomic and racial/ethnic disparities in long-term health. We
assessed if the social patterning of pathogen burden changed over 16 years in a U.S.-represen-
tative sample. Data came from 17 660 National Health and Nutrition Examination Survey par-
ticipants. Pathogen burden was quantified by summing the number of positive serologies for
cytomegalovirus, herpes simplex virus-1, HSV-2, human papillomavirus and Toxoplasma gon-
dii and dividing by the number of pathogens tested, giving a percent-seropositive for each par-
ticipant. We examined sex- and age-adjusted mean pathogen burdens from 1999–2014,
stratified by race/ethnicity and SES (poverty-to-income ratio (PIR); educational attainment).
Those with a PIR < 1.3 had a mean pathogen burden 1.4–1.8 times those with a PIR > 3.5, with
no change over time. Educational disparities were even greater and showed some evidence of
increasing over time, with the mean pathogen burden among those with less than a high
school education approximately twice that of those who completed more than high school.
Non-Hispanic Black, Mexican American and other Hispanic participants had a mean patho-
gen burden 1.3–1.9 times non-Hispanic Whites. We demonstrate that socioeconomic and
racial/ethnic disparities in pathogen burden have persisted across 16 years, with little evidence
that the gap is closing.
Background
Socioeconomic and racial/ethnic disparities in health have been reported in the literature for
decades, with those in lower socioeconomic groups and members of racial and ethnic minor-
ities often experiencing higher proportions of and more severe adverse health events. These
disparities exist across a range of health outcomes, including infectious diseases [1, 2], cogni-
tion and Alzheimer’s disease [3], cancers [4], reproductive outcomes [5], cardiovascular health
outcomes [6], and injuries [7]. While some of this heterogeneity in the distribution of health
and disease by sociodemographic factors can be explained by differential access to care or
health behaviours [8], a growing body of research points to the potential role of prevalent, per-
sistent pathogens as an important mechanism through which social factors lead to differences
in long-term health [9–12].
Persistent pathogens are pathogens that establish latent infections in the body and are never
cleared but are maintained in a latent state by the immune system. Examples of these infec-
tions include herpesviruses, such as herpes simplex virus-1 (HSV-1), cytomegalovirus
(CMV) and varicella zoster virus; Toxoplasma gondii (T. gondii); and many other viruses, bac-
teria and parasites. Often these infections cause no clinical symptoms, with some key excep-
tions, including congenital CMV infection. Due to their lack of acute health effects, many of
these pathogens have been under-studied, historically, in both epidemiologic and biomedical
research.
More recently, research has suggested that these latent infections may have long-term direct
health consequences [13–16]. For example, researchers have shown that CMV partially med-
iates the relationship between socioeconomic status (SES) and mortality [13] and that inflam-
matory cytokines mediate the relationship between CMV seropositivity and mortality [16].
Many of these latent infections are thought to affect health through similar immunologic path-
ways, including: (1) direct tissue destruction via localised inflammation, whereby pathogens
found in various organs elicit a local immune response in which the immune cells attack
the local tissue [17]; (2) the triggered release of pro-inflammatory cytokines (innate immune
response), which increases the number of circulating inflammatory markers [18] or (3)
molecular mimicry, a process through which antibodies targeted against such pathogens
may cross-react with and attack host tissues expressing proteins
homologous to those contained by the pathogen [19]. The overlap
in the mechanisms through which each latent infection impacts the
body suggests that infection with multiple pathogens may have a
cumulative health impact above and beyond infection with a single
pathogen, and points to total pathogen burden (i.e. the cumulative
number of pathogens that an individual is infected with) as a
potentially important indicator of health status. Indeed, high levels
of total pathogen burden are now an established risk factor for ath-
erosclerosis and cardiovascular disease [20, 21].
Socially disadvantaged groups (e.g. low SES, racial/ethnic
minorities) have a higher prevalence of latent infections, higher
immunoglobulin G (IgG) antibodies to those infections and
higher levels of total pathogen burden. For example, low SES
has been associated with a higher prevalence of CMV, Epstein–
Barr virus (EBV) and HSV-1 [12, 22]. Low SES has also been
associated with a greater total number of persistent infections
across the life course in the United States (U.S.), from childhood
[10] through adulthood [11, 23]. Similarly, consistent disparities
by racial and ethnic categories in the U.S. have also been seen
with individual infections [22, 24, 25] and burden [11], with
non-Hispanic Whites having the lowest prevalence and burden
compared to racial/ethnic minorities such as non-Hispanic
Blacks and Hispanic populations. Importantly, these disparities
remain after adjustment for SES [11, 22, 24, 25].
While there is strong evidence for socioeconomic and racial/
ethnic disparities in pathogen burden [10–12, 22–26], whether
and how these patterns have changed over time is currently
unknown. In this paper, we use data from a nationally represen-
tative U.S. sample to quantify the magnitude of racial/ethnic and
socioeconomic disparities in pathogen burden and assess how this
disparity has changed over a 16-year period.
Methods
Study population
The data for the present study come from the 1999–2014
National Health and Nutrition Examination Surveys
(NHANES), a population-based survey that uses a multistage
stratified probability sample designed to provide nationally rep-
resentative estimates of the civilian noninstitutionalised U.S.
population. The 16 years of data were collected and pooled
across eight survey waves. Each wave consisted of an independ-
ent, cross-sectional, U.S. representative survey. Full details on
the NHANES study design and response rates have been pub-
lished previously [27–29].
All adults aged 18–49 years old who participated in the labora-
tory component of the survey [30] and who had valid test results
were eligible for inclusion in the present analysis (n = 24 269). The
laboratory subset is a random subset of the NHANES population
and, using appropriate survey weighting procedures designed by
NHANES, is representative of the civilian noninstitutionalised
U.S. population at this age group [30]. We excluded observations
with missing data on infections, income, education, and/or race/
ethnicity for a final sample size of 17 660 across the 16-year
study period (Figure S1). The NHANES study protocols were
approved by the Research Ethics Board of the National Center
for Health Statistics, CDC.
Measures
Pathogen burden
The outcome for this analysis was pathogen burden, a composite
measure of seropositivity to several pathogens, including: CMV,
HSV-1, HSV-2, human papillomavirus (HPV) and T. gondii.
The pathogens chosen were based on their ability to establish
chronic infections in participants, their availability in NHANES
and considerations about treatment availability and vaccination
effects. For example, Hepatitis B was excluded due to the high
prevalence of vaccination to that virus. EBV, though a herpes-
virus, was also excluded due to only being measured in children
ages 6 to 19 years. HPV, however, was included as the vaccine
was only approved in 2006 for women and 2009 for men and
recommended for ages 11–12, as well as 13–26 if not already vac-
cinated. Therefore, the earlier years of HPV data are not affected,
and the later years would only have a small proportion of the
NHANES populations affected by the vaccine: women ages 18–
26 in 2006 or men ages 21–26 in 2009 who received the vaccine
and aged into the eligible population by 2014. The specific patho-
gens included in the mean pathogen burden score calculations
varied over the study period and their prevalences are shown in
Table 1. Details on the laboratory testing procedures and informa-
tion on which HPV strains were tested can be found in the CDC
NHANES Laboratory Data documentation [30].
For each participant, we quantified pathogen burden by sum-
ming the number of pathogens for which the participant was
seropositive. To account for differences in the total number of
pathogens assessed over time, we standardised the pathogen bur-
den measure by dividing the total number of pathogens for each
participant by the number of available pathogens in that year and
multiplied by 100, resulting in a percentage ranging from 0–100.
We also conducted a sensitivity analysis, replicating our results
with a pathogen burden measure that only represented HSV-1
and HSV-2 burden, which were measured across all years.
Table 1. Descriptive statistics of 1999–2014 NHANES population by study wave, n = 17 660
1999–2000 2001–2002 2003–2004 2005–2006 2007–2008 2009–2010 2011–2012 2013–2014
N 1775 2349 2097 2332 2327 2484 2190 2112
HSV-1 (% seropositive) 62.5 62.1 59.6 58.1 59.6 56.1 58.0 52.4
HSV-2 (% seropositive) 21.2 20.9 19.3 19.6 18.5 17.7 18.4 14.3
CMV (% seropositive) 55.8 54.7 52.2 – – – – –
HPV (% seropositive) – – 25.0 36.7 28.9 32.7 6.5 6.8
T. gondii (% seropositive) – 11.7 13.4 – – 11.0 9.0 9.2
Table 2. Descriptive statistics of 1999–2014 NHANES population by socioeconomic indicators, n = 17 660
Overall
PIR category Educational attainment
<1.3 1.3–1.85 >1.85–3.5 >3.5 <HS HS diploma >HS
N 17 660 5587 2308 4104 5474 4082 9558 4020
Age (years), median (IQR) 35 (27, 42) 31 (24, 39) 32 (25, 40) 34 (27, 41) 37 (30, 44) 34 (26, 41) 34 (26, 42) 36 (29, 42)
Female, % 50.8 55.6 50.6 49.5 48.8 47.1 50.7 53.2
Race, %
Non-Hispanic White 65.8 48.3 51.6 65.1 80.1 39.4 67.7 77.1
Non-Hispanic Black 11.4 16.9 15.6 12.2 6.7 15.1 12.7 6.8
Mexican American 10.1 18.5 17.2 9.3 3.9 29.4 8.1 3.0
Other Hispanic 6.3 10.5 8.3 6.5 3.2 11.3 6.1 3.6
Other 6.4 5.9 7.3 6.8 6.2 4.7 5.4 9.4
Birth country, %
U.S.-born 82.1 74.0 73.2 83.7 90.2 62.3 87.3 83.1
Foreign-born 17.9 26.0 26.8 16.3 9.8 37.7 12.7 16.9
Refused/don’t know 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Marital status, %
Married 53.1 37.0 46.1 53.7 64.2 47.7 49.3 63.8
Widowed 0.5 0.8 0.8 0.4 0.3 0.9 0.5 0.3
Divorced/separated 10.8 14.0 12.3 11.1 8.3 11.2 12.6 7.0
Never married 25.5 33.4 29.1 25.1 20.3 24.8 27.4 22.2
Living with a partner 10.1 14.7 11.7 9.7 6.9 15.4 10.2 6.7
Education level, %
<HS diploma 16.1 34.5 24.1 13.6 4.8 – – –
HS diploma, some college, AA 56.0 57.4 62.3 66.4 47.4 – – –
College graduate+ 27.9 8.0 13.6 20.0 47.9 – – –
Ratio of family income to poverty, %
<1.30 23.0 – – – – 49.9 23.6 6.6
1.30–1.85 11.1 – – – – 16.8 12.3 5.4
>1.85–3.5 24.7 – – – – 21.0 29.3 17.7
>3.5 41.2 – – – – 12.3 34.8 70.4
HSV-1 (% seropositive) 58.6 68.3 64.5 58.7 51.2 77.5 59.0 53.1
HSV-2 (% seropositive) 18.8 24.9 21.1 19.0 14.4 25.8 20.1 12.2
CMV (% seropositive) 54.2 69.4 61.0 54.9 43.6 76.5 54.3 39.3
HPV (% seropositive) 23.2 25.3 22.5 23.3 21.9 26.6 24.1 19.5
T. gondii (% seropositive) 10.9 15.5 15.1 9.8 7.5 21.3 10.3 6.7
Sociodemographics
There were three exposures for this analysis: poverty-to-income
ratio (PIR), educational attainment, and racial and ethnic
categorization.
The PIR was calculated by dividing the total family income by
the annual poverty threshold as determined by the U.S. Census
Bureau, based on the household size. A PIR < 1 indicates that
family income was below the poverty threshold. Four categories
were created for household income: low (PIR < 1.30), low-middle
(PIR⩾ 1.30 to ⩽1.85), middle (PIR > 1.85 to ⩽3.50), and high
(PIR > 3.50). This categorization scheme is based on the U.S.
Department of Agriculture’s Supplemental Nutrition Assistance
Program (SNAP) and Special Supplemental Nutrition Program
for Women, Infants and Children (WIC) programs’ income eligi-
bility cut-points for food assistance through SNAP (PIR⩽ 1.30)
or WIC (PIR ⩽ 1.85) as recommended in the NHANES
Analytic and Reporting Guidelines [31]. The highest income
group (PIR > 3.50) was used as the reference category.
We categorised educational attainment into three groups based
on highest degree achieved: less than a high school diploma, high
school diploma and/or some college, and college degree and/or
graduate education, based on recommended cut points in the
NHANES guidelines [31]. The highest education category was
used as the reference group for analysis.
We utilised the following racial and ethnic categories provided
by NHANES and available at all waves: Mexican American, Other
Hispanic, Non-Hispanic White, Non-Hispanic Black, and Other
Race/Multi-Racial. For all comparisons, Non-Hispanic White
served as the reference group. The Other Race/Multi-Racial cat-
egory was excluded as an exposure since it represents a collapsed
group of many different races and ethnicities, including several
categories of Asian American, Native Americans, and those who
identify as multi-racial. As such, we cannot provide meaningful
interpretation of this category, though if more granular measures
are available in future waves, they would be worth exploring.
Covariates
All analyses were adjusted for age (continuous) and biological sex
(dichotomous). Each sociodemographic indicator (PIR, educa-
tional attainment, and race/ethnicity) was assessed in a separate
analysis that did not include adjustment for the other variables,
as these social determinants are highly interrelated.
Statistical analyses
All statistical analyses were conducted in SAS 9.4 (SAS Institute,
Inc., Cary, North Carolina) and accounted for the complex survey
design and non-response. Standard descriptive statistics, includ-
ing weighted medians and interquartile ranges for continuous
variables and weighted percentages for categorical variables,
were used to characterise the study population. In order to calcu-
late age- and sex-adjusted mean pathogen burden overall and by
PIR, educational attainment, and racial/ethnic categories in each
wave of continuous NHANES, we used linear regression models.
To assess change in the relative magnitude of pathogen burden
disparities over time, we then calculated a ratio measure of the
relative burden in each socioeconomic group compared to a ref-
erent group. These ratios were calculated by dividing the mean
pathogen burden in each group by the mean pathogen burden
in the referent group. Trends were plotted graphically and
Pearson correlation tests were used to determine any statistically
significant linear associations between calendar year and magni-
tude of disparities.
Fig. 1. Mean pathogen burden, 1999 to 2014, stratified by socioeconomic and demographic indicators. (a) shows the mean sex- and age-adjusted pathogen burden
for each year stratified by the category of PIR; (b) shows the mean sex- and age-adjusted pathogen burden for each year stratified by educational attainment and (c)
shows the mean sex- and age-adjusted pathogen burden for each year stratified by the category of racial and ethnic identity. An asterisk (*) above a wave indicates
that the exposure was statistically significant compared to the referent group, at α = 0.05.
Results
Table 1 displays the prevalence of each pathogen in the study
population by study wave. Of note, the prevalence of HSV-1
decreased from 62.5% in 1999–2000 to 52.4% in 2013–2014
(P < 0.00001), and the prevalence of HSV-2 decreased from
21.2% to 14.3% (P < 0.00001). Table 2 displays descriptive statis-
tics for the total study population and stratified by the two socio-
economic indicators of PIR and educational attainment. The
lowest socioeconomic groups were younger and had a higher pro-
portion of non-Hispanic Black or Hispanic participants compared
to higher socioeconomic groups. Overall, 58.6% of participants
were seropositive for HSV-1, 18.8% for HSV-2, 54.2% for CMV,
23.2% for HPV, and 10.9% for T. gondii. With the exception of
HPV, lower SES was associated with a higher prevalence for
each pathogen.
Table S1 displays sociodemographic characteristics for the eli-
gible populations by each study year. The proportion of college
graduates increased from 26.2% of the population in 1999 to
30.7% in 2014. The proportion of the population in the most
impoverished category (PIR < 1.30) increased over the 16 years
from 22.0% in 1999–2000 to 26.4% in 2013–14.
Across all study years, decreasing SES was associated with a
higher age- and sex-adjusted mean pathogen burden (see
Fig. 1). In 1999–2000, those with a PIR below 1.3 had a mean
pathogen burden of 57.0%, while those with a PIR greater than
3.5 had a mean pathogen burden of 39.8%. By the end of the
study period, those in the lowest income category had a mean
pathogen burden of 27.6% while those in the highest income cat-
egory had a mean pathogen burden of 15.5%. Educational dispar-
ities in pathogen burden were even greater than those observed
for household income. In 1999–2000, the mean pathogen burden
was 64.1%, for those with less than a high school diploma, 45.6%
for those with a high school diploma and 34.4% for those with
more than a high school diploma. In the final study years, the
mean pathogen burdens were 30.2%, 21.7% and 15.1%, for
those with less than a high school diploma, those with a high
school diploma and those with more than a high school diploma,
respectively.
We also found persistent racial and ethnic disparities in the sex-
and age-adjusted mean pathogen burdens across time (Fig. 1).
Those identifying as non-Hispanic White had a significantly
lower mean pathogen burden across all waves compared to
Mexican Americans, Other Hispanics, and non-Hispanic Blacks,
with a mean pathogen burden of 38.5% in 1999–2000 compared
to above 60% for the other groups. This pattern continued through
to 2013–2014, when non-Hispanic Whites had a mean pathogen
burden of 17.3%, compared to 27.4% for Mexican Americans,
30.2% for non-Hispanic Blacks, and 26.5% for Other Hispanics.
Figure 2 shows the ratios of the mean pathogen burdens, fur-
ther demonstrating that the relative magnitude of these disparities
persisted across the study period. For example, in 1999–2000,
those with a PIR < 1.3 had a mean pathogen burden 1.4 times
the mean burden of those with a PIR > 3.5 (30%); by 2013–
2014, the ratio had increased to 1.8 times the mean burden.
Similar trends were observed for education and race/ethnicity.
Correlation coefficients, calculated to test linear associations
between the ratio measures and calendar year, are shown in
Table S2. Consistent with Figure 2, these results did not suggest
a reduction in the magnitude of the pathogen burden disparities
over time with the exception of a statistically significant trend
comparing those with a high school diploma to those with a col-
lege degree or higher. This disparity in pathogen burden increased
over time (r = 0.71 and P-value = 0.049).
Figure S2 and Table S3 show the results of our sensitivity ana-
lysis that was limited to HSV-1 and HSV-2, which were measured
Fig. 2. Ratios of mean pathogen burden, 1999 to 2014, by socioeconomic and demographic indicators. (a) shows the ratio of the mean sex- and age-adjusted
pathogen burdens for each year with high PIR as the referent group; (b) shows the ratio of the mean sex- and age-adjusted pathogen burdens for each year
with high-educational attainment as the referent group and (c) shows the ratio of the mean sex- and age-adjusted pathogen burdens for each year with
non-Hispanic Whites as the referent group.
across all study years. Results were similar to those seen with the
total pathogen burden score assessed in the primary analysis and
suggested that the disparity in pathogen burden by income may
even be widening.
Discussion
In this paper, we assessed temporal trends in socioeconomic and
racial/ethnic disparities in pathogen burden over 16 years. Across
all 16 years, the highest mean pathogen burden was among those
belonging to the lowest SES category. We also found that
non-Hispanic Whites consistently had the lowest mean pathogen
burden compared to the other racial/ethnic categories. While the
overall prevalence of most pathogens declined over the study per-
iod, we found no evidence that SES and racial/ethnic disparities in
pathogen burden are declining over time. In fact, for educational
attainment, the disparities appeared to be widening. To our
knowledge, ours is the first study to investigate temporal trends
in socioeconomic and racial/ethnic disparities in pathogen
burden.
Earlier research has posited several potential pathways linking
social disadvantage with a higher prevalence of infections. First,
those in socially disadvantaged groups are more likely to be
exposed to infections due to factors like overcrowding, and poor
neighbourhood environments and public sanitation [32].
Additionally, those in low SES groups might be more susceptible
to infection through influences on innate and adaptive immunity,
genetic and epigenetic changes, or influences of pre-existing
comorbidities that can modify immunity [33, 34].
The higher burden of infection among those in low SES groups
is compounded by the fact that these same individuals may be less
able to control infections once established. Reasons for this are
several fold and may include mechanisms related to modifications
in immune response to existing chronic or latent infections, influ-
ences on comorbidities, and genetic and epigenetic changes
[35, 36]. For example, prior research has documented that low
SES is associated with higher levels of CMV antibodies, suggesting
a diminished ability to keep the virus in a quiescent state [37].
This is further supported by studies that have found that herpes-
viruses are indicators of immune system aging and may even play
a role in immunosenescence and age-related decline [15]. This
may in turn lead to a decreased ability to control infections. A
higher burden of latent infections among socially disadvantaged
groups, coupled with a potentially diminished capacity to keep
infections in a quiescent state, suggests an important role for
the immune system in perpetuating disparities in long-term
health.
Our study has limitations to note. First, seropositivity does not
capture variation in immune response, and future investigations
that assess markers such as infection-specific IgG levels would
further our understanding of the impact that disparities in patho-
gen burden may have on health. Additionally, the HPV vaccine
may have affected the seroprevalence of HPV in a small subset
of our population, particularly in the later years of the study per-
iod, which we could not capture in our data. Differential access to
HPV and other vaccines may influence trends in pathogen burden
disparities and warrants further study as the vaccines become
increasingly more common. It is also important to note that
NHANES did not consistently measure the same pathogens
from year-to-year, which we attempted to account for by standar-
dising the pathogen burden measure by the total number of
pathogens tested. The extent to which this variation may have
affected our results cannot be assessed. However, the results of
our sensitivity analysis are encouraging and showed that using a
measure of pathogen burden including only HSV-1 and HSV-2,
which were available in all study years, produced trends consistent
to those observed in the primary analysis. Our analysis was also
limited to the pathogens measured in NHANES and subsequent
studies that incorporate additional latent pathogens, such as
EBV, may provide additional insights. Finally, self-reported
income is often misreported due to social desirability and there-
fore may be subject to misclassification bias.
Despite these limitations, our study also had a number of
strengths, including 16 years of population-based data, a relatively
large sample size, and a study sample representative of the non-
institutionalised civilian U.S. population.
Previous research has demonstrated socioeconomic and racial
and ethnic disparities in pathogen burden among participants in
NHANES [10, 11, 26], and our results support and significantly
add to this prior work by comparing burden across waves and
demonstrating that the disparities in pathogen burden in the
U.S. have persisted over 16 years.
Understanding the mechanism through which these disparities
arise is essential to reducing and preventing the disproportionate
burden of disease carried by socially disadvantaged groups. Our
findings that pathogen burden continues to be higher among
low SES groups and racial/ethnic minorities may provide tangible
points for intervention to mitigate health disparities in the U.S.
Further research on measures for preventing persistent infections
among the most at-risk groups is warranted. This is particularly
relevant given that, as our sensitivity analyses indicate, the dispar-
ities may actually be widening despite evidence that prevalence of
these infections is decreasing slightly. The higher burden of latent
pathogens and potentially diminished immune response among
disadvantaged populations constitute a silent epidemic that have
allowed these pathogens to continue to fall under the radar of
most policy makers and healthcare workers. The Council for
State and Territorial Epidemiologists has made some progress
in this regard by highlighting efforts to track infection prevalence
by area-based (e.g. census tract) socioeconomic indicators as part
of the Healthy People 2020 goals [38]. Further research will also
be needed on the biological mechanisms by which multiple
pathogens influence health and mortality as an important next
step for elucidating the utility of interventions for preventing
these infections in the U.S.
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